WEST PHARMACEUTICAL SERVICES INC
WST · XNYSCIK 105770fmd_0RDFG9S53E3THDENR70K1QXWAVManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2026, 71 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1,509 | 1,599 | 1,717 | 1,840 | 2,147 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 |
| Cost of revenue | 1,008 | 1,086 | 1,172 | 1,234 | 1,379 | 1,656 | 1,751 | 1,821 | 1,895 | 1,970 |
| Gross profit | 501 | 513 | 545 | 606 | 768 | 1,176 | 1,136 | 1,129 | 999 | 1,104 |
| Realized investment gains (losses) | – | – | – | 0 | (3) | (4) | (4) | (4) | – | – |
| Research and development | 37 | 39 | 40 | 39 | 47 | 53 | 59 | 68 | 69 | 74 |
| Selling, general and administrative | 240 | 246 | 263 | 273 | 302 | 363 | 317 | 353 | 339 | 394 |
| Operating income | 195 | 226 | 240 | 297 | 407 | 752 | 734 | 676 | 570 | 585 |
| Interest expense | 8 | 8 | 8 | 9 | 8 | 8 | 8 | 9 | 3 | 1 |
| Other non-operating income (expense) | 2 | 3 | 0 | (5) | (6) | (3) | (54) | 22 | (1) | (1) |
| Income before taxes | 190 | 222 | 241 | 292 | 401 | 749 | 680 | 698 | 586 | 601 |
| Income tax expense | 54 | 81 | 41 | 59 | 73 | 107 | 115 | 122 | 108 | 122 |
| Net income from continuing operations | 135 | 142 | 199 | 233 | 329 | 642 | 565 | 576 | 478 | 479 |
| Net income | 144 | 151 | 207 | 242 | 346 | 662 | 586 | 593 | 493 | 494 |
| Net income to common shareholders | – | – | – | – | – | – | – | – | – | – |